| 2D Structure | |
| CID | 197835 |
| Target | / |
| IUPAC Name | (3S)-6,7-dimethoxy-3-[(5R)-6-methyl-7,8-dihydro-5H-[1,3]dioxolo[4,5-g]isoquinolin-5-yl]-3H-2-benzofuran-1-one |
| InChI | InChI=1S/C21H21NO6/c1-22-7-6-11-8-15-16(27-10-26-15)9-13(11)18(22)19-12-4-5-14(24-2)20(25-3)17(12)21(23)28-19/h4-5,8-9,18-19H,6-7,10H2,1-3H3/t18-,19+/m1/s1 |
| InChI Key | JZUTXVTYJDCMDU-MOPGFXCFSA-N |
| Canonical SMILES | None |
| Isomeric SMILES | None |
| Molecular Formula | C21H21NO6 |
| Molecular Weight | 383.4 |
| synonyms | ['HYDRASTINE', '118-08-1', '(-)-Hydrastine', 'NSC-757430', 'DTXSID9025409', 'DTXCID905409', '8890V3217X', '(3S)-6,7-dimethoxy-3-[(5R)-6-methyl-7,8-dihydro-5H-[1,3]dioxolo[4,5-g]isoquinolin-5-yl]-3H-2-benzofuran-1-one', '6,7-Dimethoxy-3-(5,6,7,8-tetrahydro-6-methyl-1,3-dioxolo(4,5-g)isoquinoline-5-yl)-1(3H)-isobenzo furan', 'Isocoryne', '(3S)-6,7-dimethoxy-3-((5R)-6-methyl-7,8-dihydro-5H-(1,3)dioxolo(4,5-g)isoquinolin-5-yl)-3H-2-benzofuran-1-one', '204-233-0', '(-)-beta-Hydrastine', 'beta-Hydrastine', 'HYDRASTINE (1R, 9S)', 'CHEBI:69919', 'l-Hydrastine', '(+/-)-beta-Hydrastine', '60594-55-0', '3-((5R)-6-methyl(5,6,7,8-tetrahydro-2H-1,3-dioxoleno[4,5-g]isoquinolin-5-yl))( 3S)-6,7-dimethoxy-3-hydroisobenzofuran-1-one', 'Hydrastine [USP]', 'Phthalide, 6,7-dimethoxy-3-(5,6,7,8-tetrahydro-6-methyl-1,3-dioxolo(4,5-g)isoquinolin-5-yl)-', 'EINECS 204-233-0', '(1R,9S)-beta-Hydrastine', 'BRN 0098575', 'Hydrastin', 'NSC646664', 'UNII-8890V3217X', '(3S)-rel-6,7-Dimethoxy-3-[(5R)-5,6,7,8-tetrahydro-6-methyl-1,3-dioxolo[4,5-g]isoquinolin-5-yl]-1(3H)-isobenzofuranone; (+/-)-Hydrastine;', 'Hydrastine (Standard)', '(+/-)-b-Hydrastine', 'HYDRASTINE [MI]', 'Prestwick0_000581', 'Prestwick1_000581', 'Prestwick2_000581', 'Prestwick3_000581', '(-)-.BETA.-Hydrastine', 'HYDRASTINE [USP-RS]', 'HYDRASTINE [WHO-DD]', 'BSPBio_000422', '4-27-00-06833 (Beilstein Handbook Reference)', 'HYDRASTINE (1R 9S)', 'SCHEMBL337253', 'SPBio_002641', 'BPBio1_000466', 'orb1296164', 'CHEMBL1256919', 'SCHEMBL29549868', 'HY-B0927R', 'JZUTXVTYJDCMDU-MOPGFXCFSA-N', 'HMS2092I18', 'Pharmakon1600-01500687', 'HY-B0927', 'TNP00262', 'Tox21_200686', '(1R,9S)-(-)- beta -Hydrastine', '(1R,9S)-(-)-.beta.-Hydrastine', 'BDBM50027777', 'MSK157723', 'NSC757430', 'AKOS024282347', 'CCG-208523', 'CS-4396', 'FH61654', 'NSC 757430', 'NCGC00017326-01', 'NCGC00258240-01', 'CAS-118-08-1', 'NCI60_003057', 'ST055760', 'SBI-0206699.P002', '1ST157723', 'HYDRASTINE (CONSTITUENT OF GOLDENSEAL) [DSC]', 'BRD-K02715688-001-01-3', 'BRD-K02715688-003-03-5', 'Hydrastine, United States Pharmacopeia (USP) Reference Standard', '(3S)-6,7-dimethoxy-3-[(5R)-6-methyl-7,8-dihydro-5H-[1,3]dioxolo[4,5-g]isoquinolin-5-yl]-3H-isobenzofuran-1-one', '(S)-6,7-Dimethoxy-3-(R)-(6-methyl-5,6,7,8-tetrahydro-[1,3]dioxolo[4,5-g]isoquinolin-5-yl)isobenzofuran-1(3H)-one', '6,7-dimethoxy-3-[(5R)-5,6,7,8-tetrahydro-6-methyl-1,3-dioxolo[4,5-g]isoquinolin-5-yl]-, (3S)-', 'PHTHALIDE (S)-6,7-DIMETHOXY-3-(R)-(5,6,7,8-TETRAHYDRO-6-METHYL-1,3-DIOXOLO(4,5-G)ISOQUINOLIN-5-YL)-'] |
From Pubchem